A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel
Abstract
Publication Date:
2009
Iris type:
4.2 Abstract in Atti di convegno
List of contributors:
Cereda, S; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Nicoletti, R; Zerbi, A; Villa, E; Reni, M
Book title:
proceedings of the ASCO
Published in: